Circulating Biomarkers Market 2028 By Product, End User | The Insight Partners

report image

Circulating Biomarkers Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Circulating DNA, Circulating Tumor Cells, Other); End User (Hospitals, Medical Research Center, Others)

Report Code: TIPRE00015763 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming


Biomarkers provides a powerful way to understand chronic neurological diseases with respect to applications in epidemiology, clinical trials, and other screening aspects. Circulating biomarkers majorly includes extracellular vesicles, nucleic acids, and proteins from metastatic sites.


The circulating biomarkers market is expected to witness considerable growth due to increasing adoption of biomarkers for diagnostic purpose and rising prevalence of cancer. However, high capital investment required for circulating biomarkers is likely to hamper the growth of the global circulating biomarkers market.


The "Circulating Biomarkers Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Circulating Biomarkers Market with detailed market segmentation by product and end user. The Circulating Biomarkers Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Circulating Biomarkers Market and offers key trends and opportunities in the market.


The circulating biomarkers market is segmented on the basis of product and end user. Based on product, the market is segmented as circulating DNA, circulating tumor cells, and other. On the basis of end user, the market is segmented as hospitals, medical research center, and others.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Circulating Biomarkers Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Circulating Biomarkers Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Circulating Biomarkers Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Circulating Biomarkers market in these regions.

Get more information on this report :


The report covers key developments in the Circulating Biomarkers Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Circulating Biomarkers Market are anticipated to have lucrative growth opportunities in the future with the rising demand for smart hospital beds in the global market. Below mentioned is the list of few companies engaged in the Circulating Biomarkers Market.

The report also includes the profiles of key players in Circulating Biomarkers Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  GE Healthcare
  •  Agilent Technologies
  •  Epigenomics AG
  •  Fluxion Biosciences
  •  Affymetrix
  •  BD
  •  Abbott Laboratories
  •  Biocept

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Get more information on this report :

The List of Companies

1. GE Healthcare
2. Agilent Technologies
3. Epigenomics AG
4. Fluxion Biosciences
5. Affymetrix
6. BD
7. Abbott Laboratories
8. Biocept
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount